Operating Company Healthcare

Cooper Consumer Health

Paris, Île-de-France, France

Cooper Consumer Health has grown into Europe’s largest independent pure-play self-care platform. It develops, manufactures and distributes a broad portfolio of self-care brands and serves more than 100,000 pharmacies and drugstores across Europe and beyond.

Focus Areas
OTC pharmaceuticals, Consumer healthcare brands, Nutricosmetics

Tracked deals

3

3 tracked deals across 2018-2024.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Addon

2 addon · 1 divestiture

Cooper Consumer Health Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for Cooper Consumer Health. 1 2018 1 2021 1 2024

Supporting Data

Recent Transactions

  • Cooper Consumer Health Acquires Viatris' Over-the-Counter Business
    July 3, 2024
    Buyer
    Cooper Consumer Health
    Target
    Viatris Inc. Over-the-Counter (OTC) business
    Seller
    Viatris Inc.
    Industry
    Pharmaceuticals
    Location
    Pennsylvania, United States
    Type
    Divestiture

    Cooper Consumer Health has completed the acquisition of the Over-the-Counter (OTC) business of Viatris Inc., following regulatory approvals and worker council consultations. The deal brings more than 200 brands (including Betadine, Saugella, Armolipid and CB12), two manufacturing sites in Mérignac (France) and Confienza (Italy) and an R&D centre in Monza (Italy) into Cooper's platform, doubling Cooper's revenues to approximately €1.2bn.

  • Cooper Consumer Health Acquires Lashilé Beauty
    November 8, 2021
    Buyer
    Cooper Consumer Health
    Target
    Lashilé Beauty
    Industry
    Consumer Products
    Location
    France
    Type
    Addon

    Cooper Consumer Health appointed Bart Meermans as CEO and agreed to acquire French nutraceutical company Lashilé Beauty, a market leader in gummy dietary supplements in France. The deal is a bolt-on to Cooper's platform (which is PE-backed by investors including CVC, Avista Capital Partners and Charterhouse) and the Lashilé founders will become shareholders in Cooper to support international roll-out and digital growth.

  • Cooper-Vemedia (Charterhouse) Acquires 12-Brand OTC Portfolio from Sanofi
    April 16, 2018
    Buyer
    Cooper-Vemedia, Charterhouse Capital Partners
    Target
    Portfolio of 12 pharmaceutical/OTC brands from Sanofi
    Seller
    Sanofi
    Industry
    Pharmaceuticals
    Location
    France
    Type
    Addon

    Charterhouse-backed Cooper-Vemedia has acquired a portfolio of 12 over-the-counter (OTC) pharmaceutical brands from Sanofi for €158 million. The brands—spanning dermatology, well-being, eye care and other categories—are predominantly sold in France and Italy and will be integrated into Cooper-Vemedia’s pan‑European OTC platform to strengthen its product offering and market position.

Related Acquisition Pages

Pharmaceuticals Buyers & Acquisitions 2 tracked deals by Cooper Consumer Health. Consumer Products Buyers & Acquisitions 1 tracked deal by Cooper Consumer Health. Acquisitions in Pennsylvania 1 tracked deal by Cooper Consumer Health.

Related articles

Selling a company? Get in front of buyers like Cooper Consumer Health

Turn tracked acquisition activity into an outreach-ready buyer list.

Find buyers like these →